The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,460,528 in first-year total cost, median $1,315,804.
Most frequent study sections
- Special Emphasis Panel[ZAI1 SM-M (M1)]5
Most frequent institutions
- ACCESS TO ADVANCED HEALTH INSTITUTE1
- HARVARD SCHOOL OF PUBLIC HEALTH1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF NEBRASKA MEDICAL CENTER1
- UNIVERSITY OF SOUTHERN CALIFORNIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections1R01AI125141-01 | OUELLETTE, ANDRE J.SELSTED, MICHAEL E | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $1,495,694 | ZAI1 |
| 2016 | Host Targeted Therapy for Drug Resistant Salmonella and Francisella infection1R01AI125147-01 | AINSLIE, KRISTY MBLOUGH, BRUCE E | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,406,823 | ZAI1 |
| 2016 | Immunotherapy to prevent drug-resistant tuberculosis1R01AI125160-01 | BALDWIN, SUSAN LOUISECOLER, RHEA N | ACCESS TO ADVANCED HEALTH INSTITUTE, WA | $1,315,804 | ZAI1 |
| 2016 | Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia1R01AI125152-01 | KOBZIK, LESTER | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $939,359 | ZAI1 |
| 2016 | Host-Directed Immunotherapy: A "One Health" Approach1R01AI125137-01 | SANDERSON, SAM D | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $302,848 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.